Supreme Court Blocks Restrictions on Abortion Drug Mifepristone — For Now
The U.S. Supreme Court has temporarily blocked a lower court’s order restricting access to mifepristone, the widely used abortion medication. The deci...
Xeber.world
FDA
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
Dr. Makary's Exit and the Future of Cassidy's Senate Seat: Key Health Policy Shifts
FDA reporter Lizzy Lawrence joins 'The Readout LOUD' to dissect Dr. Makary's departure from his role, the policies that may endure, and the implicatio...
FDA Subpoena Battle: Rhode Island Hospital Challenges HIPAA Order Over Gender Dysphoria Drug Prescriptions
The FDA launched an investigation into medical facilities prescribing off-label drugs to minors with gender dysphoria. A HIPAA subpoena issued in July...
Who Will Lead the FDA Next? The Search for a New Commissioner Heats Up
As Marty Makary prepares to leave the FDA, speculation grows over his successor. Meanwhile, Louisiana politics takes a dramatic turn with Senator Bill...
Kyle Diamantas Named Acting FDA Commissioner Amid Biotech Sector Optimism
Kyle Diamantas has been appointed acting commissioner of the FDA following Marty Makary's resignation. Industry experts anticipate a stable, drama-fre...
Pharma CEOs Urge Next FDA Commissioner to Restore Stability Amid Industry Turmoil
The pharmaceutical industry is calling for the next FDA commissioner to restore stability after months of turmoil, including leadership changes and st...
Supreme Court Blocks Louisiana’s Bid to Restrict Abortion Pill Access Nationwide
The U.S. Supreme Court has temporarily blocked Louisiana’s attempt to restrict nationwide access to abortion pills via telehealth and mail order. The...
Trump Administration Speeds Up FDA Commissioner Search After Makary Resignation
The Trump administration is accelerating efforts to appoint a new FDA commissioner following Marty Makary's resignation. The ideal candidate must rest...
Gene Therapy Viruses Linked to Rare Tumor in Young Patient: FDA Commissioner Resigns Amid Safety Concerns
FDA Commissioner Marty Makary resigns after reports link gene therapy viruses to a boy's tumor. Acting Commissioner Kyle Diamantas to temporarily lead...
FDA Commissioner Marty Makary Resigns Amid Leadership Controversy; Eli Lilly Weight Loss Drug Trial Results Released
FDA Commissioner Marty Makary resigns after months of internal scrutiny, with Kyle Diamantas stepping in as acting commissioner. Meanwhile, Eli Lilly'...
FDA Commissioner Marty Makary Resigns Amid Growing Criticism of Agency Leadership
FDA Commissioner Marty Makary has resigned from his position after months of speculation. Kyle Diamantas, the agency’s top food regulator, will serve...
FDA Commissioner Marty Makary's Sudden Exit Leaves Agency in Turmoil Amid Leadership Vacuum
Marty Makary's abrupt departure from the FDA removes a key Trump administration lightning rod but fails to resolve deep organizational instability. Wi...
RFK Jr.’s Anti-Vaccine Stance Faces Backlash as Trump Aligns with Pro-Science Policies
Robert F. Kennedy Jr.’s influence within the Trump administration has sharply declined in recent weeks, with key allies removed and pro-vaccine figure...
FDA Commissioner Marty Makary Resigns Amid Trump Administration Shake-Up
FDA Commissioner Marty Makary resigned under pressure on December 18, 2025, following reports that President Donald Trump approved his removal. Makary...
FDA Commissioner Marty Makary Resigns Amid Trump Administration Health Policy Disputes
FDA Commissioner Marty Makary resigned on Tuesday after clashing with the Trump administration over health policies, including flavored vapes and abor...
FDA Commissioner Marty Makary Resigns Amid White House Pressure Over E-Cigarette Approval
FDA Commissioner Marty Makary announced his resignation on Tuesday, days after reports revealed the White House had approved plans to remove him. Form...
FDA Commissioner Marty Makary Resigns Over Agency’s Approval of Flavored Nicotine Vapes
FDA Commissioner Marty Makary resigned after the agency approved non-tobacco and non-menthol flavored nicotine vapes from Glas, citing concerns over u...
Former FDA Commissioner Marty Makary Criticized as Worst in 25 Years
A longtime FDA observer argues that Marty Makary, who resigned under pressure this week, was the worst commissioner in the agency's history over the p...
Right to Try Law Fails Patients Despite FDA Rejection of RP1 Melanoma Therapy
The FDA’s rejection of RP1, an experimental melanoma treatment, highlights the limitations of the 2018 Right to Try Act. Despite its promise to grant...
Abortion Pill Case Heads to Supreme Court as Trump Loses Control Over Issue Ahead of Midterms
Six months before the midterms, abortion pills are back at the Supreme Court as Louisiana and drug manufacturers push for fast-tracked oral arguments....
FDA Commissioner Marty Makary Resigns Amidst Controversy
FDA Commissioner Marty Makary has resigned from his position, according to breaking news coverage by Jonathan Cohn and Andrew Egger. The resignation c...
FDA Commissioner Marty Makary Resigns After 13 Months Amid Policy and Leadership Turmoil
FDA Commissioner Marty Makary is stepping down after a 13-month tenure marked by organizational upheaval, drug approval controversies, and White House...
FDA Chief Marty Makary Resigns Amid Policy Disputes with Trump Administration
Marty Makary, head of the Food and Drug Administration, announced his resignation on Tuesday, becoming the latest Trump Cabinet member to leave office...
FDA Commissioner Marty Makary Resigns Amid Leadership Turmoil; Kyle Diamantas Named Acting Head
FDA Commissioner Marty Makary is stepping down after just over a year in office. Kyle Diamantas, the agency’s top food regulator, will serve as acting...
Supreme Court Extends Deadline for Mifepristone Access Amid Legal Battle
The U.S. Supreme Court has extended the deadline for the FDA to respond to a legal challenge regarding mifepristone access. The decision comes as part...
Supreme Court Justice Alito Extends Stay on Mifepristone Telemedicine Prescriptions
Justice Samuel Alito extended an administrative stay halting a Fifth Circuit Court order that blocked mifepristone prescriptions via telemedicine. The...
Supreme Court Blocks Restrictions on Abortion Pill Mifepristone Until Thursday
The U.S. Supreme Court has temporarily extended access to mifepristone, a widely used abortion pill, until at least Thursday. Justice Samuel Alito's o...
Trump Considers Approval of 7-OH, a Kratom-Derived Opioid, for Certain Forms
President Trump indicated on Monday that the federal government may approve some forms of 7-OH, an opioid derived from the kratom plant. While the spe...
FDA’s New Vape Policy Sparks Concerns Over Illegal Flavored Products Loophole
The FDA’s new guidance allows some manufacturers to continue selling flavored e-cigarettes and nicotine pouches without prior authorization, raising c...
Medicare’s Low Uptake of New Alzheimer’s Drugs Leaves Spending Forecasts Unchanged
Medicare’s spending projections for new Alzheimer’s drugs Leqembi and Kisunla have been slashed due to minimal uptake, with no significant spending ex...